Longee, D. C., He, X., Wikstrand, C. J., Fuller, G. N., Bigner, S. H., Fredman, P., … Bigner, D. D. (1990). EXPRESSION OF GD2 BY TUMOR CELL LINES OF NEUROECTODERMAL ORIGIN AND HUMAN GLIOMAS AS DEFINED BY AN EPITOPE-DEFINED ANTI-GD2 MONOCLONAL ANTIBODY. Journal of Neuropathology and Experimental Neurology, 49(3), 320–320. https://doi.org/10.1097/00005072-199005000-00184

Longee, D. C., X. He, C. J. Wikstrand, G. N. Fuller, S. H. Bigner, P. Fredman, J. -. E. Månsson, L. Svennerholm, and D. D. Bigner. “EXPRESSION OF GD2 BY TUMOR CELL LINES OF NEUROECTODERMAL ORIGIN AND HUMAN GLIOMAS AS DEFINED BY AN EPITOPE-DEFINED ANTI-GD2 MONOCLONAL ANTIBODY.” Journal of Neuropathology and Experimental Neurology 49, no. 3 (May 1990): 320–320. https://doi.org/10.1097/00005072-199005000-00184.

Longee DC, He X, Wikstrand CJ, Fuller GN, Bigner SH, Fredman P, et al. EXPRESSION OF GD2 BY TUMOR CELL LINES OF NEUROECTODERMAL ORIGIN AND HUMAN GLIOMAS AS DEFINED BY AN EPITOPE-DEFINED ANTI-GD2 MONOCLONAL ANTIBODY. Journal of Neuropathology and Experimental Neurology. 1990 May;49(3):320–320.

Longee, D. C., et al. “EXPRESSION OF GD2 BY TUMOR CELL LINES OF NEUROECTODERMAL ORIGIN AND HUMAN GLIOMAS AS DEFINED BY AN EPITOPE-DEFINED ANTI-GD2 MONOCLONAL ANTIBODY.” Journal of Neuropathology and Experimental Neurology, vol. 49, no. 3, Oxford University Press (OUP), May 1990, pp. 320–320. Crossref, doi:10.1097/00005072-199005000-00184.

Longee DC, He X, Wikstrand CJ, Fuller GN, Bigner SH, Fredman P, Månsson J-E, Svennerholm L, Bigner DD. EXPRESSION OF GD2 BY TUMOR CELL LINES OF NEUROECTODERMAL ORIGIN AND HUMAN GLIOMAS AS DEFINED BY AN EPITOPE-DEFINED ANTI-GD2 MONOCLONAL ANTIBODY. Journal of Neuropathology and Experimental Neurology. Oxford University Press (OUP); 1990 May;49(3):320–320.